secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0001140361-25-022001
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis annual meeting: all director nominees elected; equity plan increased by 4M shares
--------------------------------------------------------------------------------

- All four director nominees elected: Diaz (134.5M for), Hayden (133.3M), Klein (127.1M), Loscalzo (108.8M).
- Say-on-pay resolution approved with 132.6M votes in favor (95.9% of votes cast).
- Amendment to 2011 Equity Incentive Plan approved; authorized shares increased by 4M to 42.5M.
- Ratification of Ernst & Young as 2025 independent auditors approved with 144.6M votes in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/0001140361-25-022001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/ef20050437_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-022001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer